SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Panacea Biotec receives order from PAHO for supply of EasyFive-TT Vaccines

04 Feb 2015 Evaluate

Panacea Biotec has been elected for supply of Pentavalent Vaccine DTP-HepB-Hib by Pan American Health Organization (PAHO). The Company has been awarded for supply of 5.99 Million doses of EasyFive-TT (DTP-HepB-Hib) fully liquid Pentavalent Vaccine for calendar year 2015 & 2016 worth USD 13.49 Million (equivalent to around Rs 83.52 crore) to meet the requirements of global immunization program.

Panacea Biotec is one of India’s leading research based health management companies with established research, manufacturing and marketing capabilities.

Panacea Biotec Share Price

348.05 -8.75 (-2.45%)
24-Apr-2026 09:41 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1647.50
Dr. Reddys Lab 1325.70
Cipla 1287.00
Zydus Lifesciences 936.80
Lupin 2322.90
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×